Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
Authors:
- M. Hope RobinsonMRM. Hope Robinson
- Nancy Y. VillaNVNancy Y. Villa
- David L. JayeDJDavid L. Jaye
- Ajay K. NookaANAjay K. Nooka
- Alyssa DuffyADAlyssa Duffy
- Samuel S. McCachrenSMSamuel S. McCachren
- Jeffrey M. SwitchenkoJSJeffrey M. Switchenko
- Sierra BarnesSBSierra Barnes
- Sayalee PotdarSPSayalee Potdar
- Maryam I. AzeemMAMaryam I. Azeem
- Ava A. HorvatAHAva A. Horvat
Open Access
- 1 August 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 133 (15)
Abstract
Entry of antigen-specific T cells into human tumors is critical for immunotherapy, but the underlying mechanisms are poorly understood. Here, we combined high-dimensional spatial analyses with in vitro and in vivo modeling to study the mechanisms underlying immune infiltration in human multiple myeloma (MM) and its precursor monoclonal gammopathy of undetermined significance (MGUS). Clustered tumor growth was a feature of MM but not MGUS biopsies, and this growth pattern was reproduced in humanized mouse models. MM biopsies exhibited intralesional as well as spatial heterogeneity, with coexistence of T cell–rich and T cell–sparse regions and the presence of areas of T cell exclusion. In vitro studies demonstrated that T cell entry into MM clusters was regulated by agonistic signals and CD2-CD58 interactions. Upon adoptive transfer, antigen-specific T cells localized to the tumor site but required in situ DC–mediated antigen presentation for tumor entry. C-type lectin domain family 9 member A–positive (CLEC9A+) DCs appeared to mark portals of entry for gradients of T cell infiltration in MM biopsies, and their proximity to T cell factor 1–positive (TCF1+) T cells correlated with disease state and risk status. These data illustrate a role for tumor-associated DCs and in situ activation in promoting the infiltration of antigen-specific T cells in MM and provide insights into spatial alterations in tumor/immune cells with malignant evolution.Keywords
Funding Information
- NCI (CA197603)
This publication has 38 references indexed in Scilit:
- Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial ProgramCell, 2013
- Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone MarrowThe Journal of Immunology, 2013
- Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myelomaBlood, 2008
- Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug ResistanceCancer Research, 2008
- Enhancement of clonogenicity of human multiple myeloma by dendritic cellsJournal of Experimental Medicine, 2006
- Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal GammopathyJournal of Experimental Medicine, 2003
- T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cellsProceedings of the National Academy of Sciences, 2002
- Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cellsJournal of Clinical Investigation, 1999
- Expression of adhesion molecules LFA‐3 and N‐CAM on normal and malignant human plasma cellsBritish Journal of Haematology, 1992
- Histologic Classification and Staging of Multiple Myeloma: A Retrospective and Prospective Study of 674 CasesAmerican Journal of Clinical Pathology, 1987